It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 2016.
2016 | Navi Mumbai, Maharashtra, India | ActiveMagnovia Pharmaceutical Private Limited, a active private limited company, was established on 29 April 2016 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U52601MH2016PTC280341. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 1 professional, Its leadership includes Vishal Jaisingh Gawade (Director), Sonali Sandeep Walunj (Director), Dilip Madhukar Ramole (Director). Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at Flat No 202 Balkrushna Arcade Chs Plot No 41 Sector 28 Nerul, Navi Mumbai, Maharashtra, 400706.
U52601MH2016PTC280341
280341
29 April 2016
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Magnovia Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishal Jaisingh Gawade | Director | 29 Apr 2016 | Current |
| Sonali Sandeep Walunj | Director | 29 Apr 2016 | Current |
| Dilip Madhukar Ramole | Director | 14 Nov 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Magnovia Pharmaceutical Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 172.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2018, Magnovia Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Magnovia Pharmaceutical has a workforce of 1 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Magnovia Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magnovia Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Magnovia Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was completed.
The activity Magnovia Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai. was completed.
Progress on Dilip Madhukar Ramole was appointed as a Director was appointed as a Director on 14 Nov 2017 & has been associated with this company since 8 years 17 days . was documented.
Vishal Jaisingh Gawade was appointed as a Director was appointed as a Director on 29 Apr 2016 & has been associated with this company since 9 years 7 months . was recorded as a recent event.
The activity Sonali Sandeep Walunj was appointed as a Director was appointed as a Director on 29 Apr 2016 & has been associated with this company since 9 years 7 months . was completed.
Magnovia Pharmaceutical Private Limited was registered on 29 Apr 2016 with Roc Mumbai & aged 9 years 7 months as per MCA records. was recorded as a recent event.
The CIN of Magnovia Pharmaceutical Private Limited is U52601MH2016PTC280341.
Magnovia Pharmaceutical Private Limited is headquartered at Flat No 202 Balkrushna Arcade Chs Plot No 41 Sector 28 Nerul, Navi Mumbai, Maharashtra, 400706.
Magnovia Pharmaceutical Private Limited was incorporated on 29 April 2016.
The current directors of Magnovia Pharmaceutical Private Limited are
The primary industry of Magnovia Pharmaceutical Private Limited is Manufacturing.
Magnovia Pharmaceutical Private Limited is unlisted.
The authorized capital of Magnovia Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Magnovia Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX